AI Articles and Analysis about Drug discovery

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.

final-updated-Approaching Life Sciences and Retail Challenges from a Data Perspective – with Alberto Rizolli of V7

Approaching Life Sciences and Retail Challenges from a Data Perspective – with Alberto Rizzoli of V7

Problems in different industries can look quite similar when looked at from the perspective of data. Though diverse business problems originate from distinct domains and needs, they often share a common thread and solution. 

AI at Takeda@1x-min

Artificial Intelligence at Takeda Pharmaceuticals

Takeda Pharmaceuticals is a 240-year-old, leading biopharmaceutical company headquartered in Tokyo, Japan, with a global hub in Cambridge, Massachusetts. The company has a global presence, operating in more than 80 countries across North America, Europe and Asia.

Future of Drug Targeting – Lilly @2x-1-min

The Future of Drug Targeting and Clinical Development with Generative AI Tools – with Ramesh Durvasula of Eli Lilly

Lily is a pharmaceutical giant with a legacy dating back to its founding in 1876 by Colonel Eli Lilly. The company engages more than 9600 employees in research and development, with clinical research conducted in more than 55 countries. As of 2022, the company clocked a revenue of $28,541.4 million and made a net income of $6,244.8 million. 

AI at GSK@2x-min

Artificial Intelligence at GSK

GlaxoSmithKline (GSK) is a multinational pharmaceutical company headquartered in Brentford, UK. The company operates in over 150 countries. GSK offers a wide range of pharmaceutical products, vaccines, and consumer healthcare products, including over-the-counter medications, oral care and nutritional products.

AI at McKesson@2x-min

Artificial Intelligence at McKesson – Three Use Cases

Founded in 1833 and headquartered in Irving, Texas, since 2019, McKesson is a leading distributor of pharmaceuticals and medical supplies. They also provide health information technology and care management tools.

Strategic Adoption of Large Language Models and Generative AI – with Asif Hasan of Quantiph@2x

Strategic Adoption of Large Language Models and Generative AI – with Asif Hasan of Quantiphi

As nearly every American household has realized over the last year, large language models combined with generative AI abilities pose tremendous challenges and opportunities for enterprises of every shape and size. Just ask anyone who has heard of ChatGPT.